These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 20863223)

  • 1. A very rare case of encephalopathy in a patient with end-stage renal disease: contrast agent, ioversol.
    Ozelsancak R; Erken E; Yildiz I; Giray S; Yildirim T; Micozkadioglu H
    Ren Fail; 2010; 32(9):1128-30. PubMed ID: 20863223
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Contrast-induced encephalopathy and seizures in a patient with chronic renal insufficiency.
    Muruve DA; Steinman TI
    Clin Nephrol; 1996 Jun; 45(6):406-9. PubMed ID: 8793235
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Contrast-induced nephropathy and cardiac catheterization: evidence in support of using the iso-osmolar contrast agent iodixanol in patients with renal dysfunction.
    Ilkhanoff L; Carver J
    J Invasive Cardiol; 2005 Apr; 17(4):216-7. PubMed ID: 15831976
    [No Abstract]   [Full Text] [Related]  

  • 4. Elimination of ioversol by hemodialysis.
    Ueda J; Furukawa T; Takahashi S; Sakaguchi K
    Acta Radiol; 1996 Sep; 37(5):826-9. PubMed ID: 8915301
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ultra-low contrast volumes reduce rates of contrast-induced nephropathy in patients with chronic kidney disease undergoing coronary angiography.
    Kane GC; Doyle BJ; Lerman A; Barsness GW; Best PJ; Rihal CS
    J Am Coll Cardiol; 2008 Jan; 51(1):89-90. PubMed ID: 18174044
    [No Abstract]   [Full Text] [Related]  

  • 6. Development of a life-threatening anaphylactoid reaction following administration of ioversol in a child.
    Zuckerman GB; Riess PL; Patel L; Constantinescu AR; Rosenfeld DL
    Pediatr Radiol; 1999 Apr; 29(4):295-7. PubMed ID: 10199911
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Severe encephalopathy following cerebral arteriogram in a patient with end-stage renal disease.
    Yan J; Ramanathan V
    Semin Dial; 2013; 26(2):203-7. PubMed ID: 23406363
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fatal anaphylactoid reaction following ioversol administration.
    Jansman FG; Kieft H; Harting JW
    Pharm World Sci; 2007 Dec; 29(6):584-6. PubMed ID: 17557212
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cortical blindness following coronary angiography.
    Kwok BW; Lim TT
    Singapore Med J; 2000 Dec; 41(12):604-5. PubMed ID: 11296788
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acute renal haemodynamic effects of radiocontrast media in patients undergoing left ventricular and coronary angiography.
    Möckel M; Radovic M; Kühnle Y; Combé V; Waigand J; Schröder S; Dietz R; Frei U; Eckardt KU
    Nephrol Dial Transplant; 2008 May; 23(5):1588-94. PubMed ID: 18175785
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Incidence of contrast-induced nephropathy in patients with chronic renal insufficiency undergoing multidetector computed tomographic angiography treated with preventive measures.
    El-Hajjar M; Bashir I; Khan M; Min J; Torosoff M; DeLago A
    Am J Cardiol; 2008 Aug; 102(3):353-6. PubMed ID: 18638601
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Iodixanol: risk of subsequent contrast nephropathy in cancer patients with underlying renal insufficiency undergoing diagnostic computed tomography examinations.
    Cheruvu B; Henning K; Mulligan J; Klippenstein D; Lawrence D; Gurtoo L; Gottlieb RH
    J Comput Assist Tomogr; 2007; 31(4):493-8. PubMed ID: 17882021
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protection from contrast-induced nephropathy: is the answer in?
    Dean LS
    Catheter Cardiovasc Interv; 2003 Mar; 58(3):342-3. PubMed ID: 12594699
    [No Abstract]   [Full Text] [Related]  

  • 14. Iodinated contrast media and contrast-induced nephropathy: is there a preferred cost-effective agent?
    Sharma SK
    J Invasive Cardiol; 2008 May; 20(5):245-8. PubMed ID: 18460711
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Iso-osmolar radio contrast iodixanol in patients with chronic kidney disease.
    Tadros GM; Malik JA; Manske CL; Kasiske BL; Dickinson SE; Herzog CA; Wilson RF; Das G; Panetta CJ
    J Invasive Cardiol; 2005 Apr; 17(4):211-5. PubMed ID: 15831975
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ioversol-induced acute generalized exanthematous pustulosis: a case report.
    Hammerbeck AA; Daniels NH; Callen JP
    Arch Dermatol; 2009 Jun; 145(6):683-7. PubMed ID: 19528424
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Severe agitation and hyperventilation after contrast media application during coronary angiography.
    Moll S; Peters A; Dietz R
    Catheter Cardiovasc Interv; 1999 Feb; 46(2):200-1. PubMed ID: 10348544
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oral acetylcysteine does not protect renal function from moderate to high doses of intravenous radiographic contrast.
    Boccalandro F; Amhad M; Smalling RW; Sdringola S
    Catheter Cardiovasc Interv; 2003 Mar; 58(3):336-41. PubMed ID: 12594698
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative study of the adverse effects of various radiographic contrast media, including ioversol, a new low-osmolarity medium. II. The complement system and endothelial cells.
    Akagi M; Masaki S; Kitazumi K; Mio M; Tasaka K
    Methods Find Exp Clin Pharmacol; 1991 Sep; 13(7):449-54. PubMed ID: 1784141
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The ACTIVE Trial: comparison of the effects on renal function of iomeprol-400 and iodixanol-320 in patients with chronic kidney disease undergoing abdominal computed tomography.
    Thomsen HS; Morcos SK; Erley CM; Grazioli L; Bonomo L; Ni Z; Romano L;
    Invest Radiol; 2008 Mar; 43(3):170-8. PubMed ID: 18301313
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.